Healthcare for irregular migrants could be cost saving in EU
ICER releases first reports, while its framework is analysed
King's Fund: more NHS funding urgently needed
Locally-based care not cost saving in short term
Questions about value of Cancer Drugs Fund
UK DH consulting on statutory drug pricing scheme
AbobotulinumtoxinA cost-saving option for cervical dystonia
Agencies consider multiple factors when ICERs above thresholds
Assessing potential for increased use of RSAs in the US
Ban on trans fats may reduce inequalities in CHD mortality
Cancer: broad economic impact in the UK
CVD screening by health workers cost effective
Design important in economic evaluations of biomarkers
Extended statin prescriptions cost saving in South Africa
Favourable costs for face-to-face programs in OA
Handscan imaging device cost effective for RA in the Netherlands
Healthcare burden of prescription opioid abuse in 5 EU countries
Healthcare resource use lower with prasugrel than ticagrelor
Improving retention in HIV care "cost-effective use of resources"
Intellectual property rights impede new vaccines
Medication monitors improve TB medication adherence in China
Narrow pharmacy networks improve medication adherence
Novel neurocognitive-sparing radiotherapy worth its cost
Pertuzumab not cost effective for HER2-positive MBC
Poor value of herpes zoster vaccine at aged 50 in the US
Telemedicine has the potential to reduce costs
Trametinib + dabrafenib not cost effective in Switzerland
Use of prescription drugs decreases medical costs
Growth hormone beneficial in osteoporosis, no effects on QOL
HIQA consulting on changes to BCG vaccine programme
Icatibant to be funded by NZ PHARMAC
Nab-paclitaxel for pancreatic cancer gets a `no' from NICE
NICE does not recommend Xiapex for finger contracture
RA biosimilars anticipated to combat high-cost biologicals
Scottish Medicines Consortium accepts seven new drugs
TNF-α inhibitors get the thumbs up from NICE for spinal arthritis